PLYMOUTH, Minn., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Entellus Medical, Inc. (NASDAQ:ENTL), a medical technology company focused on delivering minimally invasive ENT procedures, today announced the Company plans to participate in two upcoming investor conferences.
  • November 28, 2017 at 1:30pm ET, Entellus management is scheduled to present at the 29 th Annual Piper Jaffray Healthcare Conference in New York, NY.  Interested parties can access the live and archived webcast at
  • December 13, 2017, Entellus management plans to participate in the Guggenheim Healthcare Conference.

About Entellus Medical, Inc.Entellus is a medical technology company focused on delivering superior patient and physician experiences through products designed for less invasive treatments.  Entellus products are used for the treatment of adult and pediatric patients with chronic and recurrent sinusitis, patients with nasal airway obstruction, as well as adult patients with persistent Eustachian tube dysfunction.  The Entellus platform of products provides safe, effective and easy-to-use solutions intended to enable treatment of patients in more cost-effective sites of care. Entellus's product lines including the XprESS™ ENT Dilation System, Latera™ Absorbable Nasal Implant, MiniFESS™ Surgical Instruments, XeroGel Nasal Dressing and FocESS™ Imaging & Navigation combine to enable ENT physicians to conveniently and comfortably perform a broad range of procedures in the most cost effective and efficient site of care. Entellus is committed to broadening its product portfolio with high-quality and purposeful innovations for the global ENT market.

Contact: Lynn Pieper Lewis415-937-5402